Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 372

1.

Crushed application of sofosbuvir and velpatasvir in a patient with swallowing disorder.

van Seyen M, Samson AD, Cullen L, Eastick K, Knol H, Colbers A, Burger DM.

Int J Antimicrob Agents. 2020 Mar 7:105934. doi: 10.1016/j.ijantimicag.2020.105934. [Epub ahead of print] No abstract available.

PMID:
32156618
2.

Cobicistat: A case of mislabelled drug-drug interaction risk?

Burger DM, Calmy A, Marzolini C.

Br J Clin Pharmacol. 2020 Mar 6. doi: 10.1111/bcp.14262. [Epub ahead of print] No abstract available.

PMID:
32144787
3.

Hypothalamic-pituitary-adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients.

Besemer F, Kramers C, Brinkman K, Hermus ARMM, van Herwaarden AE, Burger DM.

Int J Clin Pharm. 2020 Mar 5. doi: 10.1007/s11096-020-00995-5. [Epub ahead of print]

PMID:
32140912
4.

The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients.

Benoist GE, van Oort IM, Burger DM, Mehra N, van Erp NP.

Cancer Chemother Pharmacol. 2020 Feb 19. doi: 10.1007/s00280-020-04039-7. [Epub ahead of print]

PMID:
32076807
5.

Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands.

Glerum PJ, Maliepaard M, de Valk V, Scholl JHG, van Hunsel FPAM, van Puijenbroek EP, Burger DM, Neef K.

Clin Transl Sci. 2020 Feb 12. doi: 10.1111/cts.12746. [Epub ahead of print]

PMID:
32052597
6.

Implications for IV posaconazole dosing in the era of obesity.

Wasmann RE, Smit C, van Donselaar MH, van Dongen EPA, Wiezer RMJ, Verweij PE, Burger DM, Knibbe CAJ, Brüggemann RJM.

J Antimicrob Chemother. 2020 Apr 1;75(4):1006-1013. doi: 10.1093/jac/dkz546.

7.

Pharmacokinetics of oral tenofovir disoproxil fumarate in pregnancy and lactation: a systematic review.

Bierhoff M, Smolders EJ, Tarning J, Burger DM, Spijker R, Rijken MJ, Angkurawaranon C, McGready R, White NJ, Nosten F, van Vugt M.

Antivir Ther. 2019;24(7):529-540. doi: 10.3851/IMP3341.

PMID:
31868655
8.

Assessment of Maternal and Fetal Dolutegravir Exposure by Integrating Ex Vivo Placental Perfusion Data and Physiologically-Based Pharmacokinetic Modeling.

Freriksen JJM, Schalkwijk S, Colbers AP, Abduljalil K, Russel FGM, Burger DM, Greupink R.

Clin Pharmacol Ther. 2019 Dec 23. doi: 10.1002/cpt.1748. [Epub ahead of print]

PMID:
31868223
9.

A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functions.

de Rouw N, Visser S, Koolen SLW, Aerts JGJV, van den Heuvel MM, Derijks HJ, Burger DM, Ter Heine R.

Cancer Chemother Pharmacol. 2020 Jan;85(1):231-235. doi: 10.1007/s00280-019-04006-x. Epub 2019 Dec 18.

10.

Review article: clinical pharmacology of current and investigational hepatitis B virus therapies.

Smolders EJ, Burger DM, Feld JJ, Kiser JJ.

Aliment Pharmacol Ther. 2020 Jan;51(2):231-243. doi: 10.1111/apt.15581. Epub 2019 Dec 16. Review.

PMID:
31840863
11.

Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations.

Weersink RA, Burger DM, Hayward KL, Taxis K, Drenth JPH, Borgsteede SD.

Expert Opin Drug Metab Toxicol. 2020 Jan;16(1):45-57. doi: 10.1080/17425255.2020.1702022. Epub 2019 Dec 11. Review.

PMID:
31810397
12.

Quantification of cobimetinib, cabozantinib, dabrafenib, niraparib, olaparib, vemurafenib, regorafenib and its metabolite regorafenib M2 in human plasma by UPLC-MS/MS.

Krens SD, van der Meulen E, Jansman FGA, Burger DM, van Erp NP.

Biomed Chromatogr. 2020 Mar;34(3):e4758. doi: 10.1002/bmc.4758. Epub 2020 Jan 13.

13.

Effectiveness of medication review on the number of drug-related problems in patients visiting the outpatient cardiology clinic: A randomized controlled trial.

Huiskes VJB, van den Ende CHM, Kruijtbosch M, Ensing HT, Meijs M, Meijs VMM, Burger DM, van den Bemt BJF.

Br J Clin Pharmacol. 2020 Jan;86(1):50-61. doi: 10.1111/bcp.14125. Epub 2019 Dec 3.

PMID:
31663156
14.

Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients.

Mtabho CM, Semvua HH, van den Boogaard J, Irongo CF, Boeree MJ, Colbers A, Burger DM, van Crevel R, van der Ven AJAM, Kibiki GS, Tostmann A, Aarnoutse RE.

J Antimicrob Chemother. 2019 Dec 1;74(12):3537-3545. doi: 10.1093/jac/dkz368.

PMID:
31651031
15.

Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese Individuals.

Wasmann RE, Smit C, van Dongen EPH, Wiezer RMJ, Adler-Moore J, de Beer YM, Burger DM, Knibbe CAJ, Brüggemann RJM.

Clin Infect Dis. 2019 Sep 7. pii: ciz885. doi: 10.1093/cid/ciz885. [Epub ahead of print]

PMID:
31588493
16.

A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics.

Lubberman FJE, Benoist GE, Gerritsen W, Burger DM, Mehra N, Hamberg P, van Oort I, van Erp NP.

Cancer Chemother Pharmacol. 2019 Dec;84(6):1179-1185. doi: 10.1007/s00280-019-03952-w. Epub 2019 Sep 12.

17.

Retrieval of chronic hepatitis C patients. A manifesto for action to eliminate hepatitis C in the Netherlands: the CELINE project.

van Dijk M, Kracht PAM, Arends JE, Blokzijl H, Burger DM, van Erpecum KJ, van Hoek B, de Knegt RJ, Posthouwer D, Ramsoekh D, Rijnders BJA, Schinkel J, Willemse SB, van der Valk M, Drenth JPH, Behalf Of The HepNed Study Group O.

Neth J Med. 2019 May;77(4):131-138.

18.

Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and child.

Freriksen JJM, van Seyen M, Judd A, Gibb DM, Collins IJ, Greupink R, Russel FGM, Drenth JPH, Colbers A, Burger DM.

Aliment Pharmacol Ther. 2019 Oct;50(7):738-750. doi: 10.1111/apt.15476. Epub 2019 Aug 25. Review.

19.

Simple and Rapid Quantification of the Multi-Enzyme Targeting Antifolate Pemetrexed in Human Plasma.

van den Hombergh E, de Rouw N, van den Heuvel M, Croes S, Burger DM, Derijks J, van Erp NP, Ter Heine R.

Ther Drug Monit. 2020 Feb;42(1):146-150. doi: 10.1097/FTD.0000000000000672.

PMID:
31348117
20.

Concomitant Intake of Coca-Cola to Manage the Drug-Drug Interaction Between Velpatasvir and Omeprazole Studied in Healthy Volunteers.

van Seyen M, Colbers A, Abbink EJ, Drenth JPH, Burger DM.

Clin Pharmacol Ther. 2019 Nov;106(5):1093-1098. doi: 10.1002/cpt.1569. Epub 2019 Aug 18.

21.

Use of the Child-Pugh score in anticancer drug dosing decision making: proceed with caution - Authors' reply.

Krens SD, Lassche G, Jansman FGA, Desar IME, Lankheet NAG, Burger DM, van Herpen CML, van Erp NP.

Lancet Oncol. 2019 Jun;20(6):e290. doi: 10.1016/S1470-2045(19)30349-3. No abstract available.

PMID:
31162097
22.

The Effect of Using Pazopanib With Food vs. Fasted on Pharmacokinetics, Patient Safety, and Preference (DIET Study).

Lubberman FJE, Gelderblom H, Hamberg P, Vervenne WL, Mulder SF, Jansman FGA, Colbers A, van der Graaf WTA, Burger DM, Luelmo S, Moes DJAR, van Herpen CML, van Erp NP.

Clin Pharmacol Ther. 2019 Nov;106(5):1076-1082. doi: 10.1002/cpt.1515. Epub 2019 Jul 9.

PMID:
31125423
23.

Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients.

Singkham N, Avihingsanon A, Thammajaruk N, Ruxrungtham K, Bunupuradah T, Kiertiburanakul S, Chetchotisakd P, Burger DM, Emery S, Punyawudho B.

Pharmacogenomics. 2019 May;20(7):517-527. doi: 10.2217/pgs-2018-0196.

PMID:
31124411
24.

Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update.

Smolders EJ, Jansen AME, Ter Horst PGJ, Rockstroh J, Back DJ, Burger DM.

Clin Pharmacokinet. 2019 Oct;58(10):1237-1263. doi: 10.1007/s40262-019-00774-0. Review.

25.

Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV.

Waalewijn H, Turkova A, Rakhmanina N, Cressey TR, Penazzato M, Colbers A, Burger DM; Pediatric Antiretroviral Working Group (PAWG).

Ther Drug Monit. 2019 Aug;41(4):431-443. doi: 10.1097/FTD.0000000000000637. Review.

26.

Carbamazepine intervention in a patient with efavirenz-induced liver injury.

Jacobs TG, Burger DM, Pranger AD, Khoo SH, Drenth JPH, van Crevel R.

AIDS. 2019 May 1;33(6):1097-1098. doi: 10.1097/QAD.0000000000002116. No abstract available.

PMID:
30946165
27.

Dose recommendations for anticancer drugs in patients with renal or hepatic impairment.

Krens SD, Lassche G, Jansman FGA, Desar IME, Lankheet NAG, Burger DM, van Herpen CML, van Erp NP.

Lancet Oncol. 2019 Apr;20(4):e200-e207. doi: 10.1016/S1470-2045(19)30145-7. Review.

PMID:
30942181
28.

Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis.

de Rouw N, Croes S, Posthuma R, Agterhuis DE, Schoenmaekers JJAO, Derijks HJ, Burger DM, Dingemans AM, Ter Heine R.

Lung Cancer. 2019 Apr;130:156-158. doi: 10.1016/j.lungcan.2019.01.018. Epub 2019 Feb 1.

PMID:
30885337
29.

Quantification of second generation direct-acting antivirals daclatasvir, elbasvir, grazoprevir, ledipasvir, simeprevir, sofosbuvir and velpatasvir in human plasma by UPLC-MS/MS.

van Seyen M, de Graaff Teulen MJA, van Erp NP, Burger DM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Mar 15;1110-1111:15-24. doi: 10.1016/j.jchromb.2019.01.024. Epub 2019 Jan 28.

PMID:
30776611
30.

Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling.

Schalkwijk S, Ter Heine R, Colbers A, Capparelli E, Best BM, Cressey TR, Greupink R, Russel FGM, Moltó J, Mirochnick M, Karlsson MO, Burger DM.

J Antimicrob Chemother. 2019 May 1;74(5):1348-1356. doi: 10.1093/jac/dky567.

31.

Pharmacokinetics and probability of target attainment for micafungin in normal-weight and morbidly obese adults.

Wasmann RE, Smit C, Ter Heine R, Koele SE, van Dongen EPH, Wiezer RMJ, Burger DM, Knibbe CAJ, Brüggemann RJM.

J Antimicrob Chemother. 2019 Apr 1;74(4):978-985. doi: 10.1093/jac/dky554.

PMID:
30649375
32.

Protein binding of rifampicin is not saturated when using high-dose rifampicin.

Litjens CHC, Aarnoutse RE, van Ewijk-Beneken Kolmer EWJ, Svensson EM, Colbers A, Burger DM, Boeree MJ, Te Brake LHM; PanACEA-MAMS-TB-01 Team.

J Antimicrob Chemother. 2019 Apr 1;74(4):986-990. doi: 10.1093/jac/dky527.

PMID:
30597025
33.

Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine in human plasma.

Bollen PDJ, de Graaff-Teulen MJA, Schalkwijk S, van Erp NP, Burger DM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jan 15;1105:76-84. doi: 10.1016/j.jchromb.2018.12.008. Epub 2018 Dec 10.

PMID:
30572204
34.

Successful HCV treatment of patients on contraindicated anti-epileptic drugs: Role of drug level monitoring.

van Seyen M, Smolders EJ, van Wijngaarden P, Drenth JPH, Wouthuyzen-Bakker M, de Knegt RJ, Honkoop P, El-Sherif O, Colbers A, Back DJ, Burger DM.

J Hepatol. 2019 Mar;70(3):552-554. doi: 10.1016/j.jhep.2018.10.010. Epub 2018 Nov 23. No abstract available.

PMID:
30473264
35.

The potential impact of hematocrit correction on evaluation of tacrolimus target exposure in pediatric kidney transplant patients.

Schijvens AM, van Hesteren FHS, Cornelissen EAM, Bootsma-Robroeks CMHHT, Brüggemann RJM, Burger DM, de Wildt SN, Schreuder MF, Ter Heine R.

Pediatr Nephrol. 2019 Mar;34(3):507-515. doi: 10.1007/s00467-018-4117-x. Epub 2018 Oct 30.

36.

Predictors of virological failure in HIV-1-infected patients switching to dolutegravir maintenance monotherapy.

Wijting I, Rutsaert SL, Rokx C, Burger DM, Verbon A, van Kampen J, Boucher C, Rijnders B, Vandekerckhove L.

HIV Med. 2019 Jan;20(1):63-68. doi: 10.1111/hiv.12675. Epub 2018 Sep 30.

37.

Cardiovascular Risk Management and Hepatitis C: Combining Drugs.

Smolders EJ, Ter Horst PJG, Wolters S, Burger DM.

Clin Pharmacokinet. 2019 May;58(5):565-592. doi: 10.1007/s40262-018-0710-1. Review.

38.

The Combination of Enzalutamide and Opioids: A Painful Pitfall?

Benoist GE, van Oort IM, Burger DM, Koch BCP, Mehra N, van Erp NP.

Eur Urol. 2019 Feb;75(2):351-352. doi: 10.1016/j.eururo.2018.09.011. Epub 2018 Sep 21. No abstract available.

PMID:
30245086
39.

Rifampicin Alters Metformin Plasma Exposure but Not Blood Glucose Levels in Diabetic Tuberculosis Patients.

Te Brake LHM, Yunivita V, Livia R, Soetedjo N, van Ewijk-Beneken Kolmer E, Koenderink JB, Burger DM, Santoso P, van Crevel R, Alisjahbana B, Aarnoutse RE, Ruslami R; TANDEM Consortium.

Clin Pharmacol Ther. 2019 Mar;105(3):730-737. doi: 10.1002/cpt.1232. Epub 2018 Oct 29.

40.

Pharmacokinetics of extended dose intervals of micafungin in haematology patients: optimizing antifungal prophylaxis.

Muilwijk EW, Maertens JA, van der Velden WJFM, Ter Heine R, Colbers A, Burger DM, Andes D, Theunissen K, Blijlevens NMA, Brüggemann RJM.

J Antimicrob Chemother. 2018 Nov 1;73(11):3095-3101. doi: 10.1093/jac/dky324.

PMID:
30137340
41.

Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns.

Flint RB, Ter Heine R, Spaans E, Burger DM, de Klerk JCA, Allegaert K, Knibbe CAJ, Simons SHP.

Eur J Clin Pharmacol. 2018 Dec;74(12):1585-1591. doi: 10.1007/s00228-018-2529-y. Epub 2018 Jul 28.

42.

Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps.

van der Galiën R, Ter Heine R, Greupink R, Schalkwijk SJ, van Herwaarden AE, Colbers A, Burger DM.

Clin Pharmacokinet. 2019 Mar;58(3):309-323. doi: 10.1007/s40262-018-0684-z. Review.

43.

Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.

Martial LC, van den Hombergh E, Tump C, Halmingh O, Burger DM, van Maarseveen EM, Brüggemann RJ, Aarnoutse RE.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jul 1;1089:16-23. doi: 10.1016/j.jchromb.2018.04.039. Epub 2018 Apr 27.

PMID:
29747155
44.

The Observed Effect of Gastric Bypass Surgery on Direct-acting Antiviral Treatment: a Case Report.

Smolders EJ, Willemse SB, El-Sherif O, Khoo S, Burger DM.

Ann Hepatol. 2018 May-June;17(3):525-529. doi: 10.5604/01.3001.0011.7398. Epub 2018 Apr 9.

45.

Pharmacokinetics of Anidulafungin in Obese and Normal-Weight Adults.

Wasmann RE, Ter Heine R, van Dongen EP, Burger DM, Lempers VJ, Knibbe CA, Brüggemann RJ.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00063-18. doi: 10.1128/AAC.00063-18. Print 2018 Jul.

46.

Safe use of proton pump inhibitors in patients with cirrhosis.

Weersink RA, Bouma M, Burger DM, Drenth JPH, Harkes-Idzinga SF, Hunfeld NGM, Metselaar HJ, Monster-Simons MH, van Putten SAW, Taxis K, Borgsteede SD.

Br J Clin Pharmacol. 2018 Aug;84(8):1806-1820. doi: 10.1111/bcp.13615. Epub 2018 Jun 7.

47.

The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort Study.

Knapen LM, Koornstra RHT, Driessen JHM, van Vlijmen B, Croes S, Schalkwijk S, Colbers A, Gerritsen WR, Burger DM, de Vries F, van Erp NP.

Target Oncol. 2018 Jun;13(3):363-370. doi: 10.1007/s11523-018-0564-3.

48.

Large differences in neonatal drug use between NICUs are common practice: time for consensus?

Flint RB, van Beek F, Andriessen P, Zimmermann LJ, Liem KD, Reiss IKM, de Groot R, Tibboel D, Burger DM, Simons SHP; DINO Research group.

Br J Clin Pharmacol. 2018 Jun;84(6):1313-1323. doi: 10.1111/bcp.13563. Epub 2018 Apr 17.

49.

A pharmacological rationale for improved everolimus dosing in oncology and transplant patients.

Ter Heine R, van Erp NP, Guchelaar HJ, de Fijter JW, Reinders MEJ, van Herpen CM, Burger DM, Moes DJAR.

Br J Clin Pharmacol. 2018 Jul;84(7):1575-1586. doi: 10.1111/bcp.13591. Epub 2018 May 6.

50.

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women.

Schalkwijk S, Ter Heine R, Colbers AC, Huitema ADR, Denti P, Dooley KE, Capparelli E, Best BM, Cressey TR, Greupink R, Russel FGM, Mirochnick M, Burger DM.

Clin Pharmacokinet. 2018 Nov;57(11):1421-1433. doi: 10.1007/s40262-018-0642-9.

Supplemental Content

Loading ...
Support Center